Protective effects of angiotensin II Type 1 receptor blocker on cerebral circulation independent of blood pressure

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

Björn Dahlöf, Richard B. Devereux, Sverre E. Kjeldsen et al. · The Lancet · 2002 · 5.4K citations

Medicine, Cardiology, Internal Medicine +13

Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells.

Kathy K. Griendling, C A Minieri, Jeremy D. Ollerenshaw et al. · Circulation Research · 1994 · 2.7K citations · Full text

Life Sciences, Biochemistry, Pharmacology +17

Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone.

Sanjay Rajagopalan, Stephan Kurz, Thomas Münzel et al. · Journal of Clinical Investigation · 1996 · 2.4K citations · Full text

Life Sciences, Pharmacology, Physiology +16

The Study on Cognition and Prognosis in the Elderly (SCOPE)

Hans Lithell, Lennart Hansson, Ingmar Skoog et al. · Journal of Hypertension · 2003 · 1.4K citations · Full text

Medicine, Geriatric Medicine, Pharmacotherapy +17

Morbidity and Mortality After Stroke, Eprosartan Compared With Nitrendipine for Secondary Prevention

Joachim Schrader, Stephan Lüders, Anke Kulschewski et al. · Stroke · 2005 · 763 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17